Multifunctional Nanoplatform Based on Gelatin Nanoparticles with Immunomodulatory Capabilities for Combined Immunotherapy and Chemotherapy of Melanoma
Biomacromolecules · 2025
DOI: 10.1021/acs.biomac.5c00098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2025. Verfasst von Ying Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, P.R. Ch…. Hauptthemen laut MEDLINE: Gelatin, Doxorubicin, Nanoparticles, Immunotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Natural Science Foundation of Jilin Province, Ministry of Science and Technology of the People's Republic of China, People's Government of Jilin Province.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Tumor immunotherapy has shown considerable therapeutic potential, especially when combined with chemotherapy. In this study, we developed a multifunctional nanoplatform GNPs-DOX/R848 that combined immunotherapy and chemotherapy for the treatment of melanoma, in which gelatin nanoparticles (GNPs) were loaded with the immunomodulatory agent resiquimod (R848) and the chemotherapy drug doxorubicin (DOX). GNPs possessed inherent immunomodulatory properties; when combined with R848, they induced a more pronounced polarization of M1-like macrophages by activating the NF-κB signaling pathway, thereby reversing the immunosuppressive tumor microenvironment. Meanwhile, GNPs effectively delivered R848 and DOX to tumor cells, promoting stronger therapeutic effects of the drugs, which strongly induced the immunogenic cell death triggered by DOX, leading to the infiltration of T cells into the tumor tissue. The treatment of melanoma demonstrated that GNPs-DOX/R848 significantly reduced tumor volume, enhanced the therapeutic effects of chemotherapy, providing a new approach for the combined treatment of cancer with immunotherapy and chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, P.R. China.
- School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei 230026, P.R. China.
- State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry Chinese Academy of Sciences, Changchun 130022, P. R. China.
- Department of Cardiology, The Second Hospital of Jilin University, 4026 Yatai Street, Changchun 130041, PR China.
- Hospital of Stomatology, Jilin University, Changchun 130021, China.
ORCID-Profile: Miaomiao Zhang, Xiue Jiang, Jilin Tang
Förderung
- Natural Science Foundation of Jilin Province
- Ministry of Science and Technology of the People's Republic of China
- People's Government of Jilin Province
- Department of Science and Technology of Jilin Province
- National Science Fund for Distinguished Young Scholars
- National Natural Science Foundation of China
- Chinese Academy of Sciences
Zitieren
APA
Chen, Y., Zhang, M., Li, Z., Zheng, J., Zhang, Y., Guo, Q., Liu, S., Chen, Y., Wei, W., Jiang, X., & Tang, J. (2025). Multifunctional Nanoplatform Based on Gelatin Nanoparticles with Immunomodulatory Capabilities for Combined Immunotherapy and Chemotherapy of Melanoma. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c00098
Vancouver
Chen Y, Zhang M, Li Z, Zheng J, Zhang Y, Guo Q, et al. Multifunctional Nanoplatform Based on Gelatin Nanoparticles with Immunomodulatory Capabilities for Combined Immunotherapy and Chemotherapy of Melanoma. Biomacromolecules. 2025. doi:10.1021/acs.biomac.5c00098
BibTeX
@article{Chen2025,
author = {Chen, Ying and Zhang, Miaomiao and Li, Zongjia and Zheng, Jinyao and Zhang, Yuanhao and Guo, Qianyu and Liu, Suzhen and Chen, Yu and Wei, Wei and Jiang, Xiue and Tang, Jilin},
title = {Multifunctional Nanoplatform Based on Gelatin Nanoparticles with Immunomodulatory Capabilities for Combined Immunotherapy and Chemotherapy of Melanoma},
journal = {Biomacromolecules},
year = {2025},
doi = {10.1021/acs.biomac.5c00098}
}
EUVIMED